Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   A Dual-Readout F(2) Assay That Combines Fluorescence Resonance Energy Transfer and Fluorescence Polarization for Monitoring Bimolecular Interactions
  2. Du, Y. H.; Nikolovska-Coleska, Z.; Qui, M.; Li, L.; Lewis, I.; Dingledine, R.; Stuckey, J. A.; Krajewski, K.; Roller, P. P.; Wang, S. M.; Fu, H. A.
  3. Assay and Drug Development Technologies. 2011, Aug; 9(4): 382-393.
  1. 2.   Widening the bottleneck: Increasing success in protein expression and purification
  2. Hopkins, R.; Esposito, D.; Gillette, W.
  3. Journal of Structural Biology. 2010, Oct; 172(1): 14-20.
  1. 3.   High Throughput Screening of Normal and Neoplastic Tissue Samples
  2. Erickson, H. S.; Gannot, G.; Tangrea, M. A.; Chuaqui, R. F.; Gillespie, J. W.; Emmert-Buck, M. R.
  3. Combinatorial Chemistry & High Throughput Screening. 2010, Mar; 13(3): 253-267.
  1. 4.   Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
  2. Issaq, H. J.; Blonder, J.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2009 877(13): 1222-1228.
  1. 5.   Proteomic profiling of differentiating osteoblasts
  2. Blonder, J.; Xiao, Z.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2006, Oct; 3(5): 483-496.
  1. 6.   Sleeping beauty: a novel cancer gene discovery tool
  2. Dupuy, A. J.; Jenkins, N. A.; Copeland, N. G.
  3. Human Molecular Genetics. 2006, Apr; 15: R75-R79.
  1. 7.   Integration of digital signal processing technologies with pulsed electron paramagnetic resonance imaging
  2. Pursley, R. H.; Salem, G.; Devasahayam, N.; Subramanian, S.; Koscielniak, J.; Krishna, M. C.; Pohida, T. J.
  3. Journal of Magnetic Resonance. 2006, FEB; 178(2): 220-227.
  1. 8.   Analysis of mass spectral serum profiles for biomarker selection
  2. Ressom, H. W.; Varghese, R. S.; bdel-Hamid, M.; Eissa, S. A. L.; Saha, D.; Goldman, L.; Petricoin, E. F.; Conrads, T. P.; Veenstra, T. D.; Loffredo, C. A.; Goldman, R.
  3. Bioinformatics. 2005, NOV 1; 21(21): 4039-4045.
  1. 9.   International collaboration in drug discovery and development from natural sources
  2. Cragg, G. M.; Newman, D. J.
  3. Pure and Applied Chemistry. 2005, NOV; 77(11): 1923-1942.
  1. 10.   Anthrax biosensor, protective antigen ion channel asymmetric blockade
  2. Halverson, K. M.; Panchal, R. G.; Nguyen, T. L.; Gussio, R.; Little, S. F.; Misakian, M.; Bavari, S.; Kasianowicz, J. J.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34056-34062.
  1. 11.   Novel tumor necrosis factor-knockout mice that lack Peyer's patches
  2. Kuprash, D. V.; Tumanov, A. V.; Liepinsh, D. J.; Koroleva, E. P.; Drutskaya, M. S.; Kruglov, A. A.; Shakhov, A. N.; Southon, E.; Murphy, W. J.; Tessarollo, L.; Grivennikov, S. L.; Nedospasov, S. A.
  3. European Journal of Immunology. 2005, MAY; 35(5): 1592-1600.
  1. 12.   Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
  2. Zagzag, D.; Salnikow, K.; Chiriboga, L.; Yee, H.; Lan, L.; Ali, M. A.; Garcia, R.; Demaria, S.; Newcomb, E. W.
  3. Laboratory Investigation. 2005, MAR; 85(3): 328-341.
  1. 13.   Proteomic patterns: their potential for disease diagnosis
  2. Xiao, Z.; Prieto, D.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J.
  3. Molecular and Cellular Endocrinology. 2005, JAN 31; 230(1-2): 95-106.
  1. 14.   Synthesis of gold nanoparticles bearing the Thomsen-Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen
  2. Svarovsky, S. A.; Szekely, Z.; Barchi, J. J.
  3. Tetrahedron-Asymmetry. 2005, JAN 24; 16(2): 587-598.
  1. 15.   Biomarkers: Mining the biofluid proteome
  2. Veenstra, T. D.; Conrads, T. P.; Hood, B. L.; Avellino, A. M.; Ellenbogen, R. G.; Morrison, R. S.
  3. Molecular & Cellular Proteomics. 2005 4(4): 409-418.
  1. 16.   Fixation and cryopreservation of whole blood and isolated mononuclear cells: Influence of different procedures on lymphocyte subset analysis by flow cytometry
  2. Pinto, L. A.; Trivett, M. T.; Wallace, D.; Higgins, J.; Baseler, M.; Terabe, M.; Belyakov, I. M.; Berzofsky, J. A.; Hildesheim, A.
  3. Cytometry Part B-Clinical Cytometry. 2005, JAN; 63B(1): 47-55.
  1. 17.   Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface resonance plasmon technology
  2. Lung, F. D. T.; Chang, C. W.; Chong, M. C.; Liou, C. C.; Li, P.; Peach, M. L.; Nicklaus, M. C.; Lou, B. S.; Roller, P. P.
  3. Peptide Science (Biopolymers). 2005 80(5): 628-635.
  1. 18.   Increasing access to clinical cancer trials and emerging technologies for minority populations: The Native American project
  2. Petereit, D. G.; Rogers, D.; Govern, F.; Coleman, N.; Osburn, C. H.; Howard, S. P.; Kaur, J.; Burhansstipanov, L.; Fowler, J. F.; Chappell, R.; Mehta, M. P.
  3. Journal of Clinical Oncology. 2004, NOV 15; 22(22): 4452-4455.
  1. 19.   Site- and subunit-specific incorporation of unnatural amino acids into HIV-1 reverse transcriptase
  2. Klarmann, G. J.; Eisenhauer, B. M.; Yi, Z.; Sitaraman, K.; Chatterjee, D. K.; Hecht, S. M.; Le Grice, S. F. J.
  3. Protein Expression and Purification. 2004, NOV; 38(1): 37-44.
  1. 20.   Proteomic patterns for early cancer detection
  2. Veenstra, T. D.; Prieto, D. A.; Conrads, T. P.
  3. Drug Discovery Today. 2004, OCT 15; 9(20): 889-897.
  1. 21.   Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA
  2. Donoghue, H. D.; Spigelman, M.; Greenblatt, C. L.; Lev-Maor, G.; Bar-Gal, G. K.; Matheson, C.; Vernon, K.; Nerlich, A. G.; Zink, A. R.
  3. Lancet Infectious Diseases. 2004, SEP; 4(9): 584-592.
  1. 22.   Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies
  2. Blonder, J.; Conrads, T. P.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2004, AUG; 1(2): 153-163.
  1. 23.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
  1. 24.   Justified chauvinism: advances in defining meiotic recombination through sperm typing
  2. Carrington, M.; Cullen, M.
  3. Trends in Genetics. 2004 20(4): 196-205.
  1. 25.   Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP)
  2. Berman, D. M.; Shih, L. M.; Burke, L. A.; Veenstra, T. D.; Zhao, Y. M.; Conrads, T. P.; Kwon, S. W.; Hoang, V.; Yu, L. R.; Zhou, M.; Kurman, R. J.; Petricoin, E. F.; Liotta, L. A.
  3. Proteomics. 2004 4(3): 812-818.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel